CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 164 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,045,105 | -11.0% | 757,771 | +0.9% | 0.27% | -7.6% |
| Q1 2024 | $31,521,988 | +105.0% | 751,060 | +93.7% | 0.29% | +73.7% |
| Q4 2023 | $15,374,278 | +419.7% | 387,652 | +260.6% | 0.17% | +377.1% |
| Q3 2023 | $2,958,290 | +60.0% | 107,496 | +97.2% | 0.04% | +59.1% |
| Q2 2023 | $1,849,151 | -7.4% | 54,499 | -1.8% | 0.02% | -18.5% |
| Q1 2023 | $1,995,847 | +14.8% | 55,471 | -13.9% | 0.03% | 0.0% |
| Q2 2022 | $1,738,000 | -91.2% | 64,454 | -88.9% | 0.03% | -91.6% |
| Q1 2022 | $19,727,000 | +96.4% | 579,192 | +122.9% | 0.32% | +122.2% |
| Q4 2021 | $10,042,000 | – | 259,895 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |